C4 Therapeutics Files Q1 2025 10-Q
Ticker: CCCC · Form: 10-Q · Filed: May 7, 2025 · CIK: 1662579
| Field | Detail |
|---|---|
| Company | C4 Therapeutics, Inc. (CCCC) |
| Form Type | 10-Q |
| Filed Date | May 7, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, biotech, financials
TL;DR
C4 Therapeutics filed its Q1 2025 10-Q. Check financials.
AI Summary
C4 Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The company, based in Watertown, MA, is involved in biological products. Key financial data and operational details for the first quarter of 2025 are presented in this filing.
Why It Matters
This filing provides investors with an update on C4 Therapeutics' financial performance and operational status for the first quarter of 2025, crucial for understanding the company's trajectory.
Risk Assessment
Risk Level: medium — Biotech companies like C4 Therapeutics often face inherent risks related to drug development, regulatory approvals, and market competition.
Key Players & Entities
- C4 Therapeutics, Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of reporting period
- 20250507 (date) — Filing date
- Watertown, MA (location) — Company headquarters
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter ended March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 7, 2025.
What is the primary business of C4 Therapeutics, Inc. according to the filing?
According to the filing, C4 Therapeutics, Inc. is in the business of Biological Products (No Diagnostic Substances).
Where is C4 Therapeutics, Inc. headquartered?
C4 Therapeutics, Inc. is headquartered at 490 Arsenal Way, Suite 120, Watertown, MA 02472.
What is the SEC file number for C4 Therapeutics, Inc.?
The SEC file number for C4 Therapeutics, Inc. is 001-39567.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 7, 2025 regarding C4 Therapeutics, Inc. (CCCC).